Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Current Anesthesiology Reports
Erschienen in: Current Anesthesiology Reports 2/2018

01.06.2018 | Transplantation Anesthesia (KG Belani, Section Editor)

Issues in Pediatric Kidney Transplantation

verfasst von: Benjamin Kloesel, Priya S. Verghese, Kumar Belani

Erschienen in: Current Anesthesiology Reports | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Pediatric kidney transplants have been performed for more than five decades. To achieve excellent patient outcomes, collaboration of multiple subspecialties is required. This manuscript will review recent advancements in different fields that relate to pediatric kidney transplantation.

Recent Findings

With improvements in patient selection, drugs, perioperative care, surgical technique and postoperative monitoring, outcomes including graft survival, patient survival, and delayed graft function/primary non-function have improved. Immunosuppressive regimens that minimize corticosteroids are increasingly implemented and long-term side effects of antirejection drugs such as infections and metabolic/endocrine dysregulation are better understood. The anesthetic management of pediatric kidney recipients has remained largely the same over the years, but newer technologies and drugs are beginning to be implemented.

Summary

The field of pediatric kidney transplantation has seen significant improvements in outcomes but still suffers from a discrepancy between graft demand and supply. The future will likely see efforts directed towards improved graft allocation policies, attempts to increase living donations, and new approaches such as alternative graft sources from tissue engineering and recovery of kidney function using regenerative medicine.
Literatur
1.
• Verghese PS. Pediatric kidney transplantation: a historical review. Pediatr Res. 2017;81(1–2):259–64. Detailed account of the development of adult and pediatric kidney transplantation in the USA along with a description of historical changes in immunosuppression, survival, and outcomes. PubMed
2.
3.
•• Dharnidharka VR, Fiorina P, Harmon WE. Kidney transplantation in children. N Engl J Med. 2014;371(6):549–58. Overview of indications, techniques, immunologic aspects, graft survival, and immunosuppression in pediatric kidney transplantation. PubMed
4.
Jalanko H, Mattila I, Holmberg C. Renal transplantation in infants. Pediatr Nephrol. 2016;31(5):725–35.PubMed
5.
Chavers B, Najarian JS, Humar A. Kidney transplantation in infants and small children. Pediatr Transplant. 2007;11(7):702–8.PubMed
6.
Beebe DS, Belani KG, Mergens P, Liao JC, So SK, Najarian JS, et al. Anesthetic management of infants receiving an adult kidney transplant. Anesth Analg. 1991;73(6):725–30.PubMed
7.
Smith JM, Biggins SW, Haselby DG, Kim WR, Wedd J, Lamb K, et al. Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant. 2012;12(12):3191–212.PubMedPubMedCentral
8.
Keith DS, Vranic G, Barcia J, Norwood V, Nishio-Lucar A. Longitudinal analysis of living donor kidney transplant rates in pediatric candidates in the United States. Pediatr Transplant. 2017;21(2).
9.
Smith JM, Brewer ED. Decreasing living donor rates in pediatric kidney transplantation: a time for action. Pediatr Transplant. 2017;21(2).
10.
• Andrews WS, Kane BJ, Hendrickson RJ. Organ allocation and utilization in pediatric transplantation. Semin Pediatr Surg. 2017;26(4):186–92. The authors describe the historical development of the kidney allocation system and highlight recent major policy changes including implementation of the Share 35 policy (October 2005) and the new kidney allocation system (December 2014). PubMed
11.
Satterthwaite R, Aswad S, Sunga V, Shidban H, Mendez RG, Bogaard T, et al. Outcome of en bloc and single kidney transplantation from very young cadaveric donors. Transplantation. 1997;63(10):1405–10.PubMed
12.
Lau KK, Berg GM, Schjoneman YG, Perez RV, Butani L. Pediatric en bloc kidney transplantation into pediatric recipients. Pediatr Transplant. 2010;14(1):100–4.PubMed
13.
Zhao WY, Zhang L, Zhu YH, Chen Y, Zhu FY, Shen Q, et al. En bloc kidneys transplanted from infant donors less than 5 kg into pediatric recipients. Transplantation. 2014;97(5):555–8.PubMed
14.
Sui M, Zhao W, Chen Y, Zhu F, Zhu Y, Zeng L, et al. Optimizing the utilization of kidneys from small pediatric deceased donors under 15 kg by choosing pediatric recipients. Pediatr Transplant. 2016;20(1):39–43.PubMed
15.
Wang HY, Li J, Liu LS, Deng RH, Fu Q, Ko DS, et al. En bloc kidney transplantation from infant donors younger than 10 months into pediatric recipients. Pediatr Transplant. 2017;21(2).
16.
Verghese P, Minja E, Kirchner V, Chavers B, Matas A, Chinnakotla S. Successful renal transplantation in small children with a completely thrombosed inferior vena cava. Am J Transplant. 2017;17(6):1670–3.PubMed
17.
•• Wasson NR, Deer JD, Suresh S. Anesthetic management of pediatric liver and kidney transplantation. Anesthesiol Clin. 2017;35(3):421–38. Contemporary review of anesthetic approaches to pediatric kidney transplantation. PubMed
18.
Salvatierra O Jr, Singh T, Shifrin R, Conley S, Alexander S, Tanney D, et al. Successful transplantation of adult-sized kidneys into infants requires maintenance of high aortic blood flow. Transplantation. 1998;66(7):819–23.PubMed
19.
Salvatierra O Jr, Millan M, Concepcion W. Pediatric renal transplantation with considerations for successful outcomes. Semin Pediatr Surg. 2006;15(3):208–17.PubMed
20.
Becker T, Neipp M, Reichart B, Pape L, Ehrich J, Klempnauer J, et al. Paediatric kidney transplantation in small children—a single centre experience. Transpl Int. 2006;19(3):197–202.PubMed
21.
Penna FJ, Harvey E, John P, Armstrong D, Luginbuehl I, Odeh RI, et al. Intra-arterial nitroglycerin for intra-operative arterial vasospasm during pediatric renal transplantation. Pediatr Transplant. 2016;20(3):463–6.PubMed
22.
• Michelet D, Brasher C, Marsac L, Zanoun N, Assefi M, Elghoneimi A, et al. Intraoperative hemodynamic factors predicting early postoperative renal function in pediatric kidney transplantation. Paediatr Anaesth. 2017;27(9):927–34. Retrospective analysis of 102 pediatric kidney transplant recipients with a focus on intraoperative hemodynamics that resulted in the identification of predictors for increased creatinine clearance on the first postoperative day. PubMed
23.
Cooper RA, Maddineni VR, Mirakhur RK, Wierda JM, Brady M, Fitzpatrick KT. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth. 1993;71(2):222–6.PubMed
24.
Robertson EN, Driessen JJ, Booij LH. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure. Eur J Anaesthesiol. 2005;22(1):4–10.PubMed
25.
Carlos RV, Torres ML, de Boer HD. The use of rocuronium and sugammadex in paediatric renal transplantation: two case reports. Eur J Anaesthesiol. 2016;33(5):383–6.PubMed
26.
Min KC, Lasseter KC, Marbury TC, Wrishko RE, Hanley WD, Wolford DG, et al. Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment. Int J Clin Pharmacol Ther. 2017;55(9):746–52.PubMed
27.
de Souza CM, Tardelli MA, Tedesco H, Garcia NN, Caparros MP, Alvarez-Gomez JA, et al. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: a comparative prospective clinical trial. Eur J Anaesthesiol. 2015;32(10):681–6.PubMed
28.
Panhuizen IF, Gold SJ, Buerkle C, Snoeck MM, Harper NJ, Kaspers MJ, et al. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment. Br J Anaesth. 2015;114(5):777–84.PubMed
29.
Staals LM, Snoeck MM, Driessen JJ, Flockton EA, Heeringa M, Hunter JM. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth. 2008;101(4):492–7.PubMed
30.
• Taylor K, Lorenzo A, Mertens L, Dragulescu A. Pilot study on the feasibility of limited focused real-time echocardiography during pediatric renal transplantation. Pediatr Transplant. 2016;20(6):778–82. Pilot study that introduces echocardiography into the intraoperative management of pediatric kidney transplant recipients. PubMed
31.
Lin IH, Lin CP, Lin FS, Liu CC, Hung MH, Fan SZ. The role of transesophageal echocardiography in transplantation of an adult-sized kidney to a small child. Acta Anaesthesiol Taiwanica. 2012;50(4):185–7.
32.
Taylor K, Kim WT, Maharramova M, Figueroa V, Ramesh S, Lorenzo A. Intraoperative management and early postoperative outcomes of pediatric renal transplants. Paediatr Anaesth. 2016;26(10):987–91.PubMed
33.
Chavers BM, Sullivan EK, Tejani A, Harmon WE. Pre-transplant blood transfusion and renal allograft outcome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant. 1997;1(1):22–8.PubMed
34.
Verghese P, Gillingham K, Matas A, Chinnakotla S, Chavers B. Post-transplant blood transfusions and pediatric renal allograft outcomes. Pediatr Transplant. 2016;20(7):939–45.PubMedPubMedCentral
35.
Nehus E, Goebel J, Abraham E. Outcomes of steroid-avoidance protocols in pediatric kidney transplant recipients. Am J Transplant. 2012;12(12):3441–8.PubMed
36.
Nehus E, Liu C, Hooper DK, Macaluso M, Kim MO. Clinical practice of steroid avoidance in pediatric kidney transplantation. Am J Transplant. 2015;15(8):2203–10.PubMed
37.
McDonald RA, Smith JM, Ho M, Lindblad R, Ikle D, Grimm P, et al. Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant. 2008;8(5):984–9.PubMed
38.
Naesens M, Salvatierra O, Benfield M, Ettenger RB, Dharnidharka V, Harmon W, et al. Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation. Am J Transplant. 2012;12(10):2730–43.PubMedPubMedCentral
39.
•• Chinnakotla S, Verghese P, Chavers B, Rheault MN, Kirchner V, Dunn T, et al. Outcomes and risk factors for graft loss: lessons learned from 1,056 pediatric kidney transplants at the University of Minnesota. J Am Coll Surg. 2017;224(4):473–86. Large retrospective analysis of a prospectively maintained database for pediatric kidney transplants performed in a single center. The authors describe changes in immunosuppressive regimens, graft, and patient survival over a time period of 53 years and list risk factors associated with an increased risk for graft loss. PubMed
40.
•• Van Arendonk KJ, Boyarsky BJ, Orandi BJ, James NT, Smith JM, Colombani PM, et al. National trends over 25 years in pediatric kidney transplant outcomes. Pediatrics. 2014;133(4):594–601. Large retrospective analysis of 17,446 pediatric kidney transplants performed in the USA between 1987 and 2012. Outcomes are reported and compared according to time period. PubMedPubMedCentral
41.
Garcia C, Pestana JM, Martins S, Nogueira P, Barros V, Rohde R, et al. Collaborative Brazilian pediatric renal transplant registry (CoBrazPed-RTx): a report from 2004 to 2013. Transplant Proc. 2015;47(4):950–3.PubMed
42.
Papachristou F, Stabouli S, Printza N, Mitsioni A, Stefanidis C, Miserlis G, et al. Long-term outcome of pediatric kidney transplantation: a single-center experience from Greece. Pediatr Transplant. 2016;20(4):500–6.PubMed
43.
Yamada A, Tashiro A, Hiraiwa T, Komatsu T, Kinukawa T, Ueda N. Long-term outcome of pediatric renal transplantation: a single center study in Japan. Pediatr Transplant. 2014;18(5):453–62.PubMed
44.
Jahnukainen T, Bjerre A, Larsson M, Tainio J, Thiesson HC, Jalanko H, et al. The second report of the Nordic Pediatric Renal Transplantation Registry 1997–2012: more infant recipients and improved graft survivals. Pediatr Transplant. 2016;20(3):364–71.PubMed
45.
Bijalwan P, Sanjeevan KV, Mathew A, Nair TB. Outcome and complications of living donor pediatric renal transplantation: experience from a tertiary care center. Indian J Urol. 2017;33(3):221–5.PubMedPubMedCentral
46.
Verghese PS, Schmeling DO, Filtz EA, Grimm JM, Matas AJ, Balfour HH, Jr. Transplantation of solid organ recipients shedding Epstein-Barr virus DNA pre-transplant: a prospective study. Clin Transplant. 2017;31(11).
47.
Verghese PS, Schmeling DO, Filtz EA, Matas AJ, Balfour HH, Jr. The impact of recipient BKV shedding before transplant on BKV viruria, DNAemia, and nephropathy post-transplant: a prospective study. Pediatr Transplant. 2017;21(5).
48.
Verghese PS, Schmeling DO, Knight JA, Matas AJ, Balfour HH Jr. Valganciclovir administration to kidney donors to reduce the burden of cytomegalovirus and Epstein-Barr virus transmission during transplantation. Transplantation. 2015;99(6):1186–91.PubMed
49.
Foster BJ, Dahhou M, Zhang X, Platt RW, Hanley JA. Change in mortality risk over time in young kidney transplant recipients. Am J Transplant. 2011;11(11):2432–42.PubMed
50.
Harambat J, Ranchin B, Bertholet-Thomas A, Mestrallet G, Bacchetta J, Badet L, et al. Long-term critical issues in pediatric renal transplant recipients: a single-center experience. Transpl Int. 2013;26(2):154–61.PubMed
51.
Samuel SM, Tonelli MA, Foster BJ, Alexander RT, Nettel-Aguirre A, Soo A, et al. Survival in pediatric dialysis and transplant patients. Clin J Am Soc Nephrol. 2011;6(5):1094–9.PubMedPubMedCentral
52.
Farrugia D, Cheshire J, Mahboob S, Begaj I, Khosla S, Ray D, et al. Mortality after pediatric kidney transplantation in England—a population-based cohort study. Pediatr Transplant. 2014;18(1):16–22.PubMed
53.
•• Holmberg C, Jalanko H. Long-term effects of paediatric kidney transplantation. Nat Rev Nephrol. 2016;12(5):301–11. Review article that adresses long-term effects kidney transplantation and immunosuppressive medications with a focus on growth, development, malignancies, and neurocognitive development. PubMed
54.
Salevic P, Radovic P, Milic N, Bogdanovic R, Paripovic D, Paripovic A, et al. Growth in children with chronic kidney disease: 13 years follow up study. J Nephrol. 2014;27(5):537–44.PubMed
55.
•• Serrano OK, Bangdiwala AS, Vock DM, Chinnakotla S, Dunn TB, Finger EB, et al. Post-transplant malignancy after pediatric kidney transplantation: retrospective analysis of incidence and risk factors in 884 patients receiving transplants between 1963 and 2015 at the University of Minnesota. J Am Coll Surg. 2017;225(2):181–93. Retrospective study that provides a comprehensive analysis of incidence, risk factors, and types of post-transplant malignancies in pediatric kidney transplant recipients. PubMed
56.
Moon KH, Ko IK, Yoo JJ, Atala A. Kidney diseases and tissue engineering. Methods. 2016;99:112–9.PubMed
57.
Nowacki M, Nazarewski L, Kloskowski T, Tyloch D, Pokrywczynska M, Pietkun K, et al. Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation. Arch Med Sci. 2016;12(5):1158–73.PubMedPubMedCentral
Metadaten
Titel
Issues in Pediatric Kidney Transplantation
verfasst von
Benjamin Kloesel
Priya S. Verghese
Kumar Belani
Publikationsdatum
01.06.2018
Verlag
Springer US
Erschienen in
Current Anesthesiology Reports / Ausgabe 2/2018
Elektronische ISSN: 2167-6275
DOI
https://doi.org/10.1007/s40140-018-0269-2

Weitere Artikel der Ausgabe 2/2018

Current Anesthesiology Reports 2/2018 Zur Ausgabe

Neuromuscular Blockade (GS Murphy, Section Editor)

Profound Neuromuscular Blockade: Advantages and Challenges for Patients, Anesthesiologists, and Surgeons

Geriatric Anesthesia (S Akhtar, Section Editor)

Perioperative Outcome in Geriatric Patients

Transplantation Anesthesia (KG Belani, Section Editor)

Regional Analgesia Techniques for Adult Patients Undergoing Solid Organ Transplantation

Neuromuscular Blockade (GS Murphy, Section Editor)

Should Neuromuscular Blockade Be Routinely Reversed?

Neuromuscular Blockade (GS Murphy, Section Editor)

Neostigmine: Mechanism of Action, Dosing, and Factors Determining Adequacy of Recovery Following Administration

Transplantation Anesthesia (KG Belani, Section Editor)

Hematopoietic Stem Cell Transplantation: History and Perioperative Care of Patients Undergoing HSCT

Neu im Fachgebiet AINS

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

11.04.2024 | Rückenschmerzen | Nachrichten

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren